
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br><br>1. **SEPP1 (Selenoprotein P)**: Known for its role in selenium transport and antioxidant defense.<br>2. **MTL5 (Metallothionein-like 5)**: Involved in metal ion binding and detoxification.<br>3. **ATP5B, ATP5A1, ATP5D, ATP5I, ATP5G3, ATP5O, ATP5F1, ATP5G2, ATP5E, ATP5H, ATP5J, ATP5C1, ATP5L**: These are subunits of ATP synthase, a key enzyme in the mitochondrial electron transport chain responsible for ATP production.<br>4. **GNB2L1 (Guanine Nucleotide Binding Protein Beta Polypeptide 2-Like 1)**: Involved in signal transduction.<br>5. **GLTSCR2 (Glioma Tumor Suppressor Candidate Region Gene 2)**: Associated with cell cycle regulation and apoptosis.<br>6. **WHSC1L1 (Wolf-Hirschhorn Syndrome Candidate 1-Like 1)**: Involved in chromatin modification and transcriptional regulation.<br>7. **MMP24-AS1 (Matrix Metallopeptidase 24 Antisense RNA 1)**: May play a role in extracellular matrix remodeling.<br>8. **PVRL2 (Poliovirus Receptor-Related 2)**: Involved in cell adhesion.<br>9. **SEPW1 (Selenoprotein W, Muscle 1)**: Plays a role in antioxidant defense.<br>10. **SELK (Selenoprotein K)**: Involved in endoplasmic reticulum-associated degradation and antioxidant defense.<br>11. **VIMP (VCP-Interacting Membrane Protein)**: Associated with protein degradation pathways.<br>12. **HN1 (Hematological and Neurological Expressed 1)**: Involved in cell proliferation and differentiation.<br><br>### Step 2: List the Key Cell Type Markers<br><br>1. **SCGB1D2 (Secretoglobin Family 1D Member 2)**: Known to be expressed in mammary gland epithelial cells.<br>2. **MYEOV2 (Myeloma Overexpressed 2)**: Often associated with cancerous tissues, including breast cancer.<br>3. **STRA13 (Stimulated by Retinoic Acid 13)**: Involved in immune response and may be expressed in epithelial cells.<br><br>### Step 3: Cross-reference Known Databases<br><br>- **Human Protein Atlas**: SCGB1D2 is highly expressed in mammary gland epithelial cells.<br>- **PanglaoDB**: SCGB1D2 is a marker for epithelial cells in breast tissue.<br>- **Literature**: SEPP1 and SELK are often associated with oxidative stress responses in epithelial cells.<br><br>### Step 4: Determine the Most Probable General Cell Type<br><br>Based on the expression of SCGB1D2, MYEOV2, and the presence of multiple ATP synthase subunits, the most probable general cell type is **epithelial cells**. These cells are known for their high metabolic activity, which aligns with the expression of ATP synthase subunits.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br><br>1. **Luminal Epithelial Cells**: SCGB1D2 is a strong marker for luminal epithelial cells in the breast.<br>2. **Basal Epithelial Cells**: While less likely, some markers like PVRL2 can be expressed in basal cells.<br>3. **Cancerous Epithelial Cells**: Given the context of breast cancer tissue, these markers could also indicate a cancerous epithelial cell subtype.<br><br>**Most Likely Subtype**: Luminal Epithelial Cells, due to the strong expression of SCGB1D2 and the context of breast tissue.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br><br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the expression of SCGB1D2, a known marker for luminal epithelial cells in the mammary gland, and the presence of multiple ATP synthase subunits indicating high metabolic activity typical of epithelial cells. The context of breast cancer further supports the possibility of these being cancerous luminal epithelial cells.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - SCGB1D2, a strong marker for luminal epithelial cells, is included and is known to be expressed in mammary gland epithelial cells, which aligns with the annotation of epithelial cells, specifically luminal epithelial cells.<br>   - The presence of multiple ATP synthase subunits supports the high metabolic activity typical of epithelial cells.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of basal epithelial cells and cancerous epithelial cells, which is appropriate given the context of breast cancer tissue. However, the strong expression of SCGB1D2 and the context of breast tissue strongly support the annotation of luminal epithelial cells as the most likely subtype.<br><br>Overall, the annotation is well-supported by the marker list and the context provided, and no significant evidence suggests the presence of a mixed cell type population that would require further investigation.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">epithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>luminal epithelial cells</li><li>basal epithelial cells</li><li>cancerous epithelial cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough and methodical approach to identifying the cell types present in the single-cell RNA sequencing dataset from breast cancer tissue. The analysis is well-structured, starting with the identification of key functional markers and cell type markers, followed by cross-referencing with known databases and literature. This approach ensures that the annotations are scientifically grounded.<br><br>1. **Correctness of the Annotations**: The annotation correctly identifies epithelial cells as the main cell type, with a focus on luminal epithelial cells. This is supported by the presence of SCGB1D2, a well-known marker for luminal epithelial cells in the mammary gland. The consideration of ATP synthase subunits aligns with the high metabolic activity typical of epithelial cells, further supporting the annotation.<br><br>2. **Balanced Consideration of Multiple Markers**: The analysis effectively balances the use of different markers. It does not overly focus on a single marker but instead considers a range of markers, including SEPP1, SELK, and ATP synthase subunits, to build a comprehensive picture of the cell type. The inclusion of markers like MYEOV2 and STRA13, which are associated with cancerous tissues and immune response, respectively, adds depth to the analysis.<br><br>3. **Ability to Capture the General Picture**: The annotation captures the general picture of the cell populations present, considering both the primary cell type and potential subtypes. The mention of basal epithelial cells and cancerous epithelial cells reflects an understanding of the complexity of breast cancer tissue. However, the analysis could have further explored the potential for mixed cell populations, given the heterogeneity often observed in cancerous tissues.<br><br>4. **Consideration of Marker Rank**: While the analysis does not explicitly discuss the rank of markers, it appropriately emphasizes SCGB1D2, which appears later in the list but is crucial for identifying luminal epithelial cells. This suggests a focus on biological relevance rather than strict adherence to marker order, which is a strength in this context.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and provides a comprehensive view of the cell types present. There are no obvious misclassifications or oversights, and the analysis is consistent with the context of breast cancer tissue.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    